Biodetection BARDA-NCATS Partner with Vunjak-Novakovic Laboratory at Columbia University on Tissue-Chip Technology by Global Biodefense Staff September 24, 2021
Biodetection Harvard’s Wyss Institute Receives Funding to Advance ‘Vaccination-on-a-chip’ Technology by Global Biodefense Staff September 24, 2021
Biodetection HHS Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2 by Global Biodefense Staff September 23, 2021
Biodetection OraSure Awarded $13.6M From BARDA to Advance COVID-19 Rapid Test by Global Biodefense Staff September 23, 2021
Biosurveillance BD21 Biosensor Redesign: DHS Seeks Contractors to Improve Urban BioThreat Classification Sensor by Global Biodefense Staff September 3, 2021
CBRNE Air Force Nuclear Weapons Center Pandemic Case Management Suite RFI by Global Biodefense Staff September 1, 2021
Biosurveillance US Announces Plans for Public Health Pathogen Genomics Centers of Excellence by Global Biodefense Staff July 14, 2021
Funding News Licensing Opportunity: Virus-Like Particle Technology for Universal Flu Vaccine by Global Biodefense Staff July 13, 2021
Funding News NIAID to Create New Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern by Global Biodefense Staff July 13, 2021
CBRNE RFI Supports Research on Impact of Nuclear Incident on the Microbiome and Development of Targeted Therapeutics by Global Biodefense Staff June 6, 2021
Funding News New Initiative to Support Studies of the Bat Immune System by Global Biodefense Staff April 7, 2021
Decontamination Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies by Global Biodefense Staff March 11, 2021
Biodetection DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor by Global Biodefense Staff March 10, 2021
Funding News 2021 BAA for Development of Medical Countermeasures for Biological Threats by Global Biodefense Staff March 2, 2021
Funding News UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx) by Global Biodefense Staff March 2, 2021
Funding News Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients by Global Biodefense Staff January 30, 2021
Funding News DoD Awards Funding to Pulmotect to Study Repurposed PUL-042 Against COVID-19 by Global Biodefense Staff January 27, 2021
Antimicrobial Resistance Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development by Global Biodefense Staff January 26, 2021
Funding News OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics by Global Biodefense Staff December 1, 2020
Funding News Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity by Global Biodefense Staff November 25, 2020
